Study identifier:NIS-IEU-DUM-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Observational study to assess clinical management patterns in patients with hospitalised Community-Acquired Pneumonia (CAP) or complicated Skin and Skin Structure Infections (cSSSI)
Community Acquired Pneumonia (CAP)
-
No
-
All
4035
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Dec 2013 by AstraZeneca
AstraZeneca
-
This study will collect real-life data from patients with community acquired pneumonia (CAP) OR complicated skin and skin structure infections (cSSSI) to assess the burden of the disease, review the treatment pathways, evaluate how health resources are used and identify any areas of unmet medical needs. The aim of the study is to compare how patients who are admitted to hospital with CAP or cSSSI are managed across Europe. This will be done by collecting data to understand the patient and disease characteristics, current practice of treatment, and outcomes for the patient. Overall 4000 patients will be recruited from 10 European countries.
Location
Location
Brussel, Belgium
Location
Montigny-le-Tilleul, Belgium
Location
Godinne, Belgium
Location
Mons, Belgium
Location
Aalst, Belgium
Location
Hasselt, Belgium
Location
Liege, Belgium
Location
Dinant, Belgium
Arms | Assigned Interventions |
---|---|
1 | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.